Currently, there is no cure for atopic dermatitis (AD), which is a type of eczema. There is a need for more effective, safer AD medicines. We are conducting a phase 2 research study evaluating the safety and effectiveness of an investigational medicine for moderate‑to‑severe AD. If you’re someone with AD and interested in advancing AD research, this study may be for you.
You’re the only person that can decide if participation is right for you. Each person and each research study are different. Every research study has risks and benefits for you to consider when deciding whether to participate.
Adults with moderate‑to‑severe atopic dermatitis may want to take part in this study for the following reasons:
Try a possible treatment that you previously have not.
Help atopic dermatitis research move forward.
Take an active role in your healthcare decisions.